Jessica Grzybowski

Views are mine

[IQVIA Institute @IQVIA_Institute]

RNA sequencing provides an opportunity to more accurately identify individuals with hereditary cancer susceptibility by increasing detection and improving classification of disease-causing variants. #Oncology #ClinicalResearch

https://t.co/HAFPePIB2c

[Jessica Grzybowski @JGrzy8]

@SammyShaya So true! RNA functional evidence is so important to consider 🧬

[Jessica Grzybowski @JGrzy8]

🥳Ambry Genetics at #ASHG2023:
📉 Reduced Inconclusive Rates
👨‍⚕️ Improved Health Equity
🧩 RNA Sequencing Impact:
• 17.1% Pathogenic Splicing Variants resolved.
• 71.1% Splicing VUSs clarified.
🔬 https://t.co/nhiNJfbTSe #EverySinglePatient #GeneChat #RNA @carrieotype @JAMAOnc

[Jessica Grzybowski @JGrzy8]

🌟 Join us at #ASHG2023 for a groundbreaking oral presentation on expanding RNA sequencing's clinical reach! 🗣️
📆 Nov 04, 2023 🕥 10:30am - 10:45am 🧬 Explore concurrent DNA and RNA testing in hereditary cancer.
https://t.co/XwHn0FWQwK #EverySinglePatient #GeneChat

[Ambry Genetics @AmbryGenetics]

Join us for a webinar tomorrow at 11am PDT. Register now: https://t.co/eUyuEemz3m

[Jessica Grzybowski @JGrzy8]

@LValleResearch @GIMJournal Great work @carrieotype and team at @AmbryGenetics!

[Laura Valle @LValleResearch]

Characterization of POT1 tumor predisposition syndrome: Tumor prevalence in a clinically diverse hereditary cancer cohort.

@GIMJournal

https://t.co/PDNpoBowdg

[Jessica Grzybowski @JGrzy8]

📢 Without the SCOTUS ruling to keep genes free, diversity and inequality of care would be even more limited!

👩‍⚕️ My colleague Jenny Geurts is a valuable member of the genetics community and her perspective is crucial as she trains the next CGCs #KeepGenesFree @MCWmsgc

[Ambry Genetics @AmbryGenetics]

Jenny Geurts, Certified Genetic Counselor, remembers the impact the SCOTUS ruling had on her patients and talks about the continued importance of striving toward health equity and best outcomes for patients. #KeepGenesFree
https://t.co/5ixTLqBR3T

[Ambry Genetics @AmbryGenetics]

Jenny Geurts, Certified Genetic Counselor, remembers the impact the SCOTUS ruling had on her patients and talks about the continued importance of striving toward health equity and best outcomes for patients. #KeepGenesFree
https://t.co/5ixTLqBR3T

[Jessica Grzybowski @JGrzy8]

@EllenMatloff your account of the day of the SCOTUS decision on gene patents is incredibly moving, thank you for your advocacy work. Genetics friends, this video is a must watch! 🔥#KeepGenesFree #GeneChat

[Ambry Genetics @AmbryGenetics]

@EllenMatloff, MS, CGC, CEO of @MyGeneCounsel remembers, “When we finally received a ruling from the Supreme Court in our favor in 2013, it was a spectacular, unexpected win.” The significance is clear: “I can’t wait to see what the next decade brings.” https://t.co/cYhsN0AT8G

[Jessica Grzybowski @JGrzy8]

@EllenMatloff

[Jessica Grzybowski @JGrzy8]

From a clinical genetic counselor to a proud employee, I've always trusted Ambry Genetics scientific excellence and mission. Now, I'm honored to be part of a team that provides accessible and equitable care to all patients. #KeepGenesFree #GeneChat https://t.co/EoAQXu2UMW

[Ambry Genetics @AmbryGenetics]

Jessie Grzybowski, MS, LCGC, Sr Medical Science Liaison, shares a poignant story about the SCOTUS ruling, the first BRCA-positive patient Ambry reported and how the experience shaped her career as a clinical genetic counselor. #KeepGenesFree https://t.co/SuaLke3ZMz

[Jessica Grzybowski @JGrzy8]

#KeepGenesFree

[Ambry Genetics @AmbryGenetics]

Runi Limary gave her patient testimony 10 years ago in the court case over BRCA1/2. She shared thoughts on the experience, her breast cancer diagnosis at the age of 28 and observations from her work in the nonprofit sector. Read more: https://t.co/QEBULFo4nf
#KeepGenesFree

[Jessica Grzybowski @JGrzy8]

💥It's been a decade since the SCOTUS, with a resounding unanimous decision, declared that naturally occurring genes like BRCA1/BRCA2 cannot be patented. 🧬✨ This ruling was a triumph for science, researcher, and for humanity! 🎉💪 #KeepGenesFree @AmbryGenetics

[Jessica Grzybowski @JGrzy8]

Join us tomorrow on the decade anniversary of your genes 🧬 being free!
#GeneChat #KeepGenesFree

[Ambry Genetics @AmbryGenetics]

Only a few spaces remain! Register for "A Landmark Ruling: Celebrating 10 Years of Gene Freedom from Patenting,” tomorrow! A panel of experts will discuss the transformational case that set an important precedent for health care. https://t.co/5NhS336kvp
#KeepGenesFree

[Ambry Genetics @AmbryGenetics]

Only a few spaces remain! Register for "A Landmark Ruling: Celebrating 10 Years of Gene Freedom from Patenting,” tomorrow! A panel of experts will discuss the transformational case that set an important precedent for health care. https://t.co/5NhS336kvp
#KeepGenesFree

[Ambry Genetics @AmbryGenetics]

Reminder: Register for the June 13 webinar.
https://t.co/hcVe5BcHrx
Join a panel of experts to learn about "A Landmark Ruling: Celebrating 10 Years of Gene Freedom from Patenting." This transformational case set an important precedent for the health care industry. #KeepGenesFree

[Jessica Grzybowski @JGrzy8]

Almost a decade ago, a monumental decision was made that forever changed the landscape of genetics. SCOTUS, in an unanimous ruling, declared that naturally occurring genes, including the BRCA1 and BRCA2, cannot be patented! 🙌✨https://t.co/yefLKiviys
#KeepGenesFree

[Ambry Genetics @AmbryGenetics]

Did you know? Ten years ago, the Supreme Court unanimously ruled naturally occurring genes such as BRCA1 and BRCA2 cannot be patented.
Register to learn about this transformational case from a panel of experts. Space is limited! #KeepGenesFree
https://t.co/th4JwLfvtD

[Ambry Genetics @AmbryGenetics]

“Germline Genetic Testing after Cancer Diagnosis” is available! https://t.co/7dx9V9Qz2n. This groundbreaking study reveals important information about population-based rates of #genetictesting utilization for hereditary #cancer. #knowyourrisks #clinicalresearch @allisonkurian

[Jessica Grzybowski @JGrzy8]

🧬 Don't miss out on May's Gene of the Month! Learn about the inspiring story of a patient who found answers through Ambry's Patient for Life program years after their exome testing. #AmbryKnowsGenes #PatientForLife #GeneChat Link: https://t.co/UAAoFQY6Ey

[Ambry Genetics @AmbryGenetics]

Senior Clinical Scientist Jennifer Huang, PhD, presents May's Gene of the Month, PTPN4. Read more: https://t.co/AZEmLQWeWC
You know your patients. #AmbryKnowsGenes
Partner with us to end diagnostic odysseys sooner and improve care for patients with rare diseases.